Benitec Biopharma (BNTC) Depreciation and Depletion (2019 - 2023)

Benitec Biopharma (BNTC) has disclosed Depreciation and Depletion for 5 consecutive years, with $19000.0 as the latest value for Q3 2023.

  • Quarterly Depreciation and Depletion fell 54.76% to $19000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $121000.0 through Sep 2023, down 22.93% year-over-year, with the annual reading at $167000.0 for FY2022, 27.71% down from the prior year.
  • Depreciation and Depletion hit $19000.0 in Q3 2023 for Benitec Biopharma, down from $42000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $67000.0 in Q4 2020 to a low of -$105000.0 in Q2 2020.
  • Historically, Depreciation and Depletion has averaged $36000.0 across 5 years, with a median of $51000.0 in 2019.
  • Biggest five-year swings in Depreciation and Depletion: soared 149.52% in 2021 and later tumbled 88.46% in 2022.
  • Year by year, Depreciation and Depletion stood at $51000.0 in 2019, then soared by 31.37% to $67000.0 in 2020, then dropped by 17.91% to $55000.0 in 2021, then decreased by 23.64% to $42000.0 in 2022, then crashed by 54.76% to $19000.0 in 2023.
  • Business Quant data shows Depreciation and Depletion for BNTC at $19000.0 in Q3 2023, $42000.0 in Q3 2022, and $6000.0 in Q2 2022.